Inhibition of intimal hyperplasia in murine aortic allografts by the oral administration of the transforming growth factor-beta receptor I kinase inhibitor SD-208.

[1]  A. Hata,et al.  Targeting the TGFβ signalling pathway in disease , 2012, Nature Reviews Drug Discovery.

[2]  K. Kent,et al.  Transforming growth factor-β increases vascular smooth muscle cell proliferation through the Smad3 and extracellular signal-regulated kinase mitogen-activated protein kinases pathways. , 2012, Journal of vascular surgery.

[3]  K. Kent,et al.  TGF-β and Smad3 modulate PI3K/Akt signaling pathway in vascular smooth muscle cells. , 2012, American journal of physiology. Heart and circulatory physiology.

[4]  E. Falk,et al.  Flanking Recipient Vasculature, Not Circulating Progenitor Cells, Contributes to Endothelium and Smooth Muscle in Murine Allograft Vasculopathy , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[5]  J. Hillebrands,et al.  Development of transplant vasculopathy in aortic allografts correlates with neointimal smooth muscle cell proliferative capacity and fibrocyte frequency. , 2010, Atherosclerosis.

[6]  R. Morishita,et al.  Characteristics of chronic rejection in heart transplantation: important elements of pathogenesis and future treatments. , 2010, Circulation journal : official journal of the Japanese Circulation Society.

[7]  S. Hollenbeck,et al.  TGF-beta through Smad3 signaling stimulates vascular smooth muscle cell proliferation and neointimal formation. , 2009, American journal of physiology. Heart and circulatory physiology.

[8]  R. Mitchell,et al.  Graft vascular disease: immune response meets the vessel wall. , 2009, Annual review of pathology.

[9]  M. Weis,et al.  Cardiac allograft vasculopathy: recent developments. , 2008, Circulation.

[10]  Marta Ruiz-Ortega,et al.  TGF-β signaling in vascular fibrosis , 2007 .

[11]  Richard N. Mitchell,et al.  This Review Is Part of a Thematic Series on Transplant Vasculopathy, Which Includes the following Articles: Allograft Vasculopathy versus Atherosclerosis Antibody and Complement in Transplant Vasculopathy Interferon-␥ Axis in Graft Arteriosclerosis Vascular Remodeling in Transplant Vasculopathy Chem , 2022 .

[12]  C. Orosz,et al.  Transforming Growth Factor Beta‐Induced Connective Tissue Growth Factor and Chronic Allograft Rejection † , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[13]  Richard A Flavell,et al.  Transforming growth factor-beta regulation of immune responses. , 2006, Annual review of immunology.

[14]  W. Seeger,et al.  Transforming Growth Factor-β-Dependent Growth Inhibition in Primary Vascular Smooth Muscle Cells Is p38-Dependent , 2005, Journal of Pharmacology and Experimental Therapeutics.

[15]  P. Libby,et al.  Host bone-marrow cells are a source of donor intimal smooth- muscle–like cells in murine aortic transplant arteriopathy , 2001, Nature Medicine.

[16]  K. Wood,et al.  Development of a combined cardiac and aortic transplant model to investigate the development of transplant arteriosclerosis in the mouse. , 2000, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[17]  P. Hasleton,et al.  Transforming growth factor β in relation to cardiac allograft vasculopathy after heart transplantation , 2000 .

[18]  D. Nance,et al.  Migration of bovine aortic smooth muscle cells after wounding injury. The role of hyaluronan and RHAMM. , 1995, The Journal of clinical investigation.

[19]  A. Miller,et al.  Long-term biological response of injured rat carotid artery seeded with smooth muscle cells expressing retrovirally introduced human genes. , 1994, The Journal of clinical investigation.

[20]  K. Kent,et al.  TGF-beta stimulates collagen (I) in vascular smooth muscle cells via a short element in the proximal collagen promoter. , 2003, The Journal of surgical research.